Morphic Holding Inc
MORF
27.17USD+0.58 (+2.18%)Market ClosedWatchlist
Market Summary
USD27.17+0.58
Market Closed2.18%
MORF Alerts
MORF Stock Price
View Fullscreen
MORF RSI Chart
MORF Alerts
MORF Valuation
MORF Price/Sales (Trailing)
MORF Profitability
MORF Fundamentals
MORF Revenue
MORF Earnings
Price Action
Last 7 days
11.3%
Last 30 days
26.2%
Last 90 days
-50.1%
Trailing 12 Months
-0.1%
How does MORF drawdown profile look like?
MORF Financial Health
MORF Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2023 | 0 | 0 | 0 | 0 |
| 2022 | 32.5M | 45.3M | 58.1M | 70.8M |
| 2021 | 42.6M | 38.8M | 16.1M | 19.8M |
| 2020 | 24.0M | 31.0M | 38.0M | 44.9M |
| 2019 | 9.1M | 14.9M | 20.7M | 17.0M |
| 2018 | 0 | 0 | 0 | 3.4M |
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for MORF
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
| Nov 13, 2023 | slattery joseph p | bought | 49,435 | 20.5982 | 2,400 | - |
| Nov 13, 2023 | edwards martin | bought | 48,803 | 20.54 | 2,376 | - |
| Sep 07, 2023 | schegerin marc | acquired | 300,000 | 15.00 | 20,000 | cfo and coo |
| Sep 07, 2023 | schegerin marc | sold | -1,086,850 | 54.3424 | -20,000 | cfo and coo |
| Aug 01, 2023 | tipirneni praveen p. | acquired | 15,539 | 4.32 | 3,597 | president and ceo |
| Aug 01, 2023 | tipirneni praveen p. | sold | -205,187 | 57.0439 | -3,597 | president and ceo |
| Jul 03, 2023 | tipirneni praveen p. | acquired | 15,539 | 4.32 | 3,597 | president and ceo |
| Jul 03, 2023 | tipirneni praveen p. | sold | -205,178 | 57.0413 | -3,597 | president and ceo |
| Jun 28, 2023 | nashat amir | acquired | - | - | 935 | - |
| Jun 28, 2023 | nashat amir | sold | - | - | -935 | - |
Which funds bought or sold MORF recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
| Dec 06, 2023 | CITIGROUP INC | added | 28.65 | -1,301,770 | 1,377,260 | -% |
| Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 21.44 | -444,803 | 419,390 | -% |
| Nov 21, 2023 | Walleye Capital LLC | new | - | 3,908,420 | 3,908,420 | 0.01% |
| Nov 15, 2023 | WOLVERINE TRADING, LLC | sold off | -100 | -216,048 | - | -% |
| Nov 15, 2023 | Virtu Financial LLC | new | - | 415,000 | 415,000 | 0.04% |
| Nov 15, 2023 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | added | 14.48 | -1,591,240 | 1,341,820 | -% |
| Nov 15, 2023 | iA Global Asset Management Inc. | reduced | -9.58 | -1,849,000 | 1,047,000 | 0.02% |
| Nov 15, 2023 | JANE STREET GROUP, LLC | added | 368 | 1,175,810 | 2,521,180 | -% |
| Nov 15, 2023 | MORGAN STANLEY | added | 101 | -2,960,440 | 12,106,500 | -% |
| Nov 15, 2023 | Tudor Investment Corp Et Al | new | - | 335,975 | 335,975 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Morphic Holding Inc
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Oct 18, 2023 | springer timothy a | 15.8% | 7,577,651 | SC 13D | |
| Oct 02, 2023 | point72 asset management, l.p. | 5.2% | 2,504,383 | SC 13G | |
| Feb 13, 2023 | artal international s.c.a. | 5.6% | 2,150,000 | SC 13G | |
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 03, 2023 | blackrock inc. | 5.4% | 2,090,925 | SC 13G | |
| Feb 22, 2022 | novo holdings a/s | 4.9% | 1,845,030 | SC 13D/A | |
| Feb 14, 2022 | ecor1 capital, llc | 10.7% | 3,951,566 | SC 13G/A | |
| Feb 14, 2022 | omega fund v, l.p. | 3.3% | 1,200,014 | SC 13G/A | |
| Feb 11, 2022 | artal international s.c.a. | 4.3% | 1,585,049 | SC 13G/A | |
| Feb 11, 2022 | polaris partners vii, l.p. | 5.3% | 1,953,960 | SC 13G/A |
Recent SEC filings of Morphic Holding Inc
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Dec 06, 2023 | 8-K | Current Report | |
| Nov 15, 2023 | 4 | Insider Trading | |
| Nov 14, 2023 | 4 | Insider Trading | |
| Nov 03, 2023 | 8-K | Current Report | |
| Nov 03, 2023 | 10-Q | Quarterly Report | |
| Oct 18, 2023 | SC 13D | 13D - Major Acquisition | |
| Oct 12, 2023 | 8-K | Current Report | |
| Oct 02, 2023 | SC 13G | Major Ownership Report | |
| Sep 26, 2023 | 8-K | Current Report | |
| Sep 08, 2023 | 4 | Insider Trading |
Peers (Alternatives to Morphic Holding Inc)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
HILS | 31.5B | - | 6.13% | 411799.31% | -3.7K | 218.4K | - | -102.45% |
MRNA | 30.6B | 10.7B | 12.59% | -56.51% | -8.83 | 2.87 | -53.67% | -129.46% |
ALNY | 21.3B | 1.7B | 0.38% | -28.56% | -41.84 | 12.38 | 79.37% | 56.87% |
BMRN | 17.5B | 2.3B | 8.71% | -10.95% | 119.09 | 7.58 | 15.05% | 75.21% |
INCY | 12.3B | 3.6B | 1.18% | -34.97% | 28.84 | 3.4 | 8.35% | -51.49% |
| MID-CAP | ||||||||
APLS | 7.4B | 272.9M | 33.62% | 24.68% | -12.26 | 27.23 | 141.38% | 4.43% |
BBIO | 5.7B | - | 10.65% | 240.88% | -9.69 | 48.33 | 54.84% | -12.96% |
ACAD | 3.4B | 631.9M | -9.53% | 43.40% | -23.12 | 5.44 | 23.54% | 31.53% |
AXSM | 3.3B | 223.4M | 14.00% | -9.85% | -16.45 | 14.86 | - | -26.24% |
ARWR | 2.6B | 240.7M | -11.63% | -24.14% | -12.52 | 10.67 | -1.03% | -16.59% |
| SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 12.92% | -15.71% | 24.33 | 4.33 | 81.69% | -7.29% |
NVAX | 661.3M | 1.0B | -18.09% | -67.84% | -1.2 | 0.63 | -43.15% | 58.48% |
INO | 100.5M | 6.4M | - | -79.35% | -0.61 | 15.6 | -44.11% | 50.48% |
IBIO | 37.6M | - | 385.71% | 119.35% | -0.58 | - | - | -29.23% |
CRBP | 23.7M | - | 40.31% | 4064.72% | -0.5 | - | - | -13.74% |
Morphic Holding Inc News
Latest updates
Financials for Morphic Holding Inc
Income Statement (Last 12 Months)
| Income Statement (Quarterly) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
| Revenue | - | - | - | - | 6,135,000 | 2,055,000 | 60,236,000 | 34,896,250 | 9,556,500 | 3,124,000 | 3,848,000 | 3,265,000 | 5,901,000 | 25,757,000 | 7,693,000 | 5,594,000 | 5,634,500 | 5,675,000 | 5,567,000 | 6,068,000 | 3,358,000 |
| Costs and Expenses | -1.2% | 44,748,000 | 45,302,000 | 39,726,000 | 32,716,000 | 33,548,000 | 33,886,000 | 34,054,000 | 31,101,500 | 28,242,000 | 31,691,000 | 24,566,000 | 23,880,000 | 20,749,000 | 24,113,000 | 23,383,000 | 20,246,000 | 15,533,000 | 15,984,000 | 12,202,000 | 9,330,000 |
| S&GA Expenses | 8.4% | 10,384,000 | 9,583,000 | 9,277,000 | 8,014,000 | 8,303,000 | 8,234,000 | 7,591,000 | 7,443,500 | 7,276,000 | 7,139,000 | 5,953,000 | 5,126,500 | 4,751,000 | 4,195,000 | 4,423,000 | 3,426,000 | 2,898,000 | 2,077,000 | 1,832,000 | - |
| R&D Expenses | -3.8% | 34,364,000 | 35,719,000 | 30,449,000 | 24,702,000 | 25,245,000 | 25,652,000 | 26,463,000 | 23,658,000 | 20,966,000 | 24,552,000 | 18,613,000 | 18,753,500 | 15,998,000 | 19,918,000 | 18,960,000 | 16,820,000 | 12,635,000 | 13,907,000 | 10,370,000 | - |
| EBITDA Margin | - | - | - | -0.88 | -0.82 | -0.95 | -2.53 | -5.29 | -4.77 | -5.64 | -1.57 | -1.15 | -0.99 | -1.19 | -3.22 | -3.23 | - | - | - | - | - |
| Income Taxes | -39.9% | 83,000 | 138,000 | 32,000 | 36,000 | 29,000 | 2,000 | - | - | - | - | - | -143,000 | -115,000 | -155,000 | -157,000 | 344,000 | 304,000 | 135,000 | 129,000 | - |
| Earnings Before Taxes | 7.1% | -36,129,000 | -38,875,000 | -36,103,000 | -24,341,000 | -29,992,000 | 26,843,000 | -31,484,000 | -21,402,000 | -25,041,000 | -27,815,000 | -21,284,000 | -17,892,000 | 5,239,000 | -16,013,000 | -16,903,000 | -19,487,500 | -8,560,000 | -9,298,000 | -5,071,000 | - |
| EBT Margin | - | - | - | -0.90 | -0.83 | -0.97 | -2.58 | -5.34 | -4.83 | -5.70 | -1.59 | -1.17 | -1.01 | -1.22 | -3.27 | -3.29 | - | - | - | - | - |
| Net Income | 7.2% | -36,212,000 | -39,013,000 | -36,135,000 | -24,377,000 | -30,021,000 | 26,841,000 | -31,484,000 | -21,402,000 | -25,041,000 | -27,815,000 | -21,284,000 | -17,749,000 | 5,354,000 | -15,858,000 | -16,746,000 | -19,831,000 | -8,864,000 | -9,433,000 | -5,200,000 | -5,343,000 |
| Net Income Margin | - | - | - | -0.90 | -0.83 | -0.97 | -2.58 | -5.34 | -4.83 | -5.69 | -1.59 | -1.16 | -1.00 | -1.22 | -3.29 | -3.33 | - | - | - | - | - |
| Free Cashflow | -26.7% | -29,555,000 | -23,327,000 | -32,004,000 | -25,182,000 | -25,143,000 | -22,821,000 | -28,196,000 | -21,042,000 | -24,936,000 | -18,062,000 | -20,441,000 | -14,487,000 | 3,641,000 | -16,450,000 | -19,238,000 | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
| Assets | -0.7% | 744 | 749 | 442 | 369 | 389 | 414 | 397 | 426 | 439 | 439 | 460 | 242 | 222 | 212 | 229 | 247 | 260 | 179 | 184 | 189 |
| Current Assets | -0.6% | 738 | 743 | 436 | 362 | 382 | 407 | 389 | 418 | 435 | 437 | 457 | 239 | 218 | 209 | 226 | 244 | 257 | 173 | - | 187 |
| Cash Equivalents | -65.6% | 75.00 | 217 | 42.00 | 59.00 | 85.00 | 141 | 120 | 172 | 184 | 399 | 396 | 102 | 98.00 | 133 | 107 | 102 | 160 | 44.00 | 42.00 | 186 |
| Net PPE | -9.1% | 2.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | - | 2.00 |
| Liabilities | 5.6% | 20.00 | 19.00 | 15.00 | 19.00 | 24.00 | 26.00 | 84.00 | 90.00 | 88.00 | 92.00 | 91.00 | 97.00 | 91.00 | 97.00 | 101 | 107 | 101 | 105 | 103 | 102 |
| Current Liabilities | 8.4% | 19.00 | 18.00 | 13.00 | 17.00 | 19.00 | 20.00 | 44.00 | 38.00 | 42.00 | 35.00 | 34.00 | 39.00 | 36.00 | 45.00 | 37.00 | 35.00 | 26.00 | 44.00 | - | 35.00 |
| Shareholder's Equity | -0.8% | 723 | 729 | 427 | 349 | 365 | 388 | 313 | 337 | 350 | 348 | 369 | 145 | 130 | 115 | 128 | 141 | 159 | - | - | - |
| Retained Earnings | -9.7% | -408 | -372 | -333 | -297 | -272 | -242 | -269 | -238 | -216 | -191 | -163 | -142 | -124 | -130 | -114 | -97.51 | -77.68 | -68.82 | - | -54.18 |
| Additional Paid-In Capital | 2.7% | 1,133 | 1,104 | 761 | 650 | 642 | 633 | 585 | 575 | 567 | 540 | 533 | 288 | 255 | 245 | 242 | 238 | 237 | 3.00 | - | 2.00 |
| Shares Outstanding | 3.9% | 50.00 | 48.00 | 40.00 | 39.00 | 39.00 | 38.00 | 37.00 | 37.00 | 37.00 | 36.00 | 34.00 | 32.00 | 31.00 | 30.00 | 30.00 | 16.00 | 30.00 | 2.00 | 2.00 | 1.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Quarterly) | (In Thousands) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
| Cashflow From Operations | -27.0% | -29,250 | -23,034 | -31,454 | -25,118 | -24,894 | -22,817 | -28,148 | -20,585 | -24,578 | -17,908 | -20,390 | -14,418 | 3,731 | -16,360 | -18,943 | -14,075 | -13,696 | -14,068 | 188 | - | - |
| Share Based Compensation | 2.1% | 10,534 | 10,315 | 9,576 | 7,123 | 7,537 | 7,623 | 6,765 | 5,643 | 5,791 | 5,308 | 4,442 | 3,024 | 2,996 | 2,489 | 2,544 | 1,377 | 989 | 667 | 499 | - | - |
| Cashflow From Investing | 0.1% | -133,082 | -133,217 | -88,401 | -1,146 | -32,509 | 3,278 | -26,074 | 5,186 | -211,961 | 19,846 | 73,749 | -11,295 | -46,051 | 41,911 | 23,616 | -44,201 | 34,204 | 17,681 | -143,670 | - | - |
| Cashflow From Financing | -94.2% | 19,288 | 331,626 | 102,484 | 575 | 1,181 | 40,880 | 2,630 | 2,674 | 21,579 | 1,481 | 240,579 | 29,680 | 7,279 | 535 | 803 | 28.00 | 95,100 | - | - | - | - |
MORF Income Statement
2023-09-30CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Collaboration revenue | $ 0 | $ 2,055 | $ 521 | $ 64,673 |
| Operating expenses: | ||||
| Research and development | 34,364 | 25,245 | 100,532 | 77,360 |
| General and administrative | 10,384 | 8,303 | 29,244 | 24,128 |
| Total operating expenses | 44,748 | 33,548 | 129,776 | 101,488 |
| Loss from operations | (44,748) | (31,493) | (129,255) | (36,815) |
| Other income: | ||||
| Interest income, net | 8,612 | 1,657 | 18,139 | 2,326 |
| Other income (expense), net | 7 | (156) | 9 | (144) |
| Total other income, net | 8,619 | 1,501 | 18,148 | 2,182 |
| Loss before provision for income taxes | (36,129) | (29,992) | (111,107) | (34,633) |
| Provision for income taxes | (83) | (29) | (253) | (31) |
| Net loss | $ (36,212) | $ (30,021) | $ (111,360) | $ (34,664) |
| Net loss per share, basic (in dollars per share) | $ (0.73) | $ (0.78) | $ (2.65) | $ (0.91) |
| Net loss per share, diluted (in dollars per share) | $ (0.73) | $ (0.78) | $ (2.65) | $ (0.91) |
| Weighted average common shares outstanding, basic (in shares) | 49,548,947 | 38,490,910 | 41,979,245 | 37,961,262 |
| Weighted average common shares outstanding, diluted (in shares) | 49,548,947 | 38,490,910 | 41,979,245 | 37,961,262 |
| Comprehensive loss: | ||||
| Net loss | $ (36,212) | $ (30,021) | $ (111,360) | $ (34,664) |
| Other comprehensive income (loss): | ||||
| Unrealized holding gains (losses) on marketable securities, net of tax | 201 | (1,680) | 1,623 | (3,615) |
| Total other comprehensive income (loss) | 201 | (1,680) | 1,623 | (3,615) |
| Comprehensive loss | $ (36,011) | $ (31,701) | $ (109,737) | $ (38,279) |
MORF Balance Sheet
2023-09-30CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 74,232 | $ 59,272 |
| Marketable securities | 650,835 | 288,976 |
| Accounts receivable | 0 | 455 |
| Prepaid expenses and other current assets | 13,030 | 13,479 |
| Total current assets | 738,097 | 362,182 |
| Operating lease right-of-use assets | 2,487 | 3,514 |
| Property and equipment, net | 2,280 | 2,119 |
| Restricted cash | 560 | 560 |
| Other assets | 178 | 214 |
| Total assets | 743,602 | 368,589 |
| Current liabilities: | ||
| Accounts payable | 5,268 | 3,475 |
| Accrued expenses | 14,030 | 13,181 |
| Deferred revenue, current portion | 0 | 470 |
| Total current liabilities | 19,298 | 17,126 |
| Long-term liabilities: | ||
| Operating lease liability, net of current portion | 1,136 | 2,344 |
| Total liabilities | 20,434 | 19,470 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ Equity | ||
| Preferred shares, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022 | 0 | 0 |
| Common shares, $0.0001 par value, 400,000,000 shares authorized, 49,742,966 shares issued and outstanding as of September 30, 2023 and 38,584,678 shares issued and outstanding as of December 31, 2022 | 5 | 4 |
| Additional paid‑in capital | 1,133,334 | 649,549 |
| Accumulated deficit | (408,455) | (297,095) |
| Accumulated other comprehensive loss | (1,716) | (3,339) |
| Total stockholders’ equity | 723,168 | 349,119 |
| Total liabilities and stockholders’ equity | $ 743,602 | $ 368,589 |
| CEO | Dr. Praveen P. Tipirneni M.D. |
|---|---|
| WEBSITE | www.morphictx.com |
| EMPLOYEES | 110 |